Table 1 clinical characteristics, primary diagnosis for admission, comorbidities, conventional medicines that were taken and cause of liver biochemistry test abnormalities
Item | Number (%) |
|---|---|
Number of patients | 138 (100) |
Gender | Male 82 (59.42), Female 56 (40.58) |
Age (mean ± SD) | 60.12 ± 14.72 |
Days of liver function test interval | 41.87 ± 33.32 |
Primary diagnosis | |
Cerebrovascular disease | 82 (59.42) |
Musculo-skeletal disorders | 17 (12.31) |
Psychiatric disorders | 15 (10.86) |
Peripheral nerve palsy | 13 (9.42) |
Vertigo | 6 (4.34) |
Other diseases | 5 (3.65) |
Comorbiditis | |
Average number of comorbiditis | 2.224 |
Hypertension | 58 (42.02) |
Diabetes mellitus | 30 (21.73) |
Cardiovascular disorders | 22 (15.94) |
Hyperlipidemia | 15 (10.86) |
Others | 12 (8.69) |
None | 39 (28.26) |
Conventional medicines | |
Average number of medicines being taken | 6.25 |
Anti-hypertension | 126 (91.30) |
Anticoagulants & Antithrombotics | 122 (88.40) |
Agent for digestive system | 109 (78.98) |
Antiepileptics & Skeletal muscle relaxants | 67 (48.55) |
Agent for arteriosclerosis | 66 (47.82) |
Antidepressants & Tranquilizers | 66 (47.82) |
Antidiabetics | 44 (31.88) |
Antiplatelet | 44 (31.88) |
Other CNS drugs | 39 (28.26) |
Other circulatory agents | 28 (20.28) |
Agents for liver diseases | 22 (15.94) |
NSIDS | 21 (15.21) |
Others | |
Cause of liver biochemistry test abnormalities | |
Acute Hepatitis | 1 (0.72) |
Chronic hepatitis B | 6 (4.35) |
Chronic hepatitis C | 0 (0) |
Alcoholic liver disease | 4 (2.90) |
Non-alcoholic fatty liver disease | 26 (18.84) |
Others | 101 (73.19) |